Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)
Showing 1 - 25 of >10,000
Rheumatoid Arthritis (RA) Trial in Brazil, China, Korea, Republic of (Upadacitinib, Placebo)
Completed
- Rheumatoid Arthritis (RA)
- Upadacitinib
- Placebo
-
Curitiba, Parana, Brazil
- +42 more
Aug 30, 2021
Rheumatoid Arthritis Trial in Dhaka (Vitamin D3)
Completed
- Rheumatoid Arthritis
- Vitamin D3
-
Dhaka, BangladeshBSMMU
Feb 1, 2022
Rheumatoid Arthritis Trial in Worldwide (Placebo, Upadacitinib)
Rheumatoid Arthritis Trial (Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD))
Not yet recruiting
- Rheumatoid Arthritis
- Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD)
- (no location specified)
Nov 12, 2021
Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Placebo)
Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)
Terminated
- Rheumatoid Arthritis
- Methotrexate
- +5 more
-
Pondicherry, IndiaDepartment of Clinical Immunology , Jawaharlal Institute of Post
Jul 25, 2021
Rheumatoid Arthritis Trial in Singapore (Musculoskeletal ultrasound program)
Completed
- Rheumatoid Arthritis
- Musculoskeletal ultrasound program
-
Singapore, Singapore(unnamed)
Oct 25, 2020
Rheumatoid Arthritis Trial (hUC-MSC suspension, Placebo)
Not yet recruiting
- Rheumatoid Arthritis
- hUC-MSC suspension
- Placebo
- (no location specified)
Aug 9, 2022
Moderated to Severe Rheumatoid Arthritis Who Have Failed to
Completed
- Arthritis, Rheumatoid
-
Ilsan, Gyeonggi-do, Korea, Republic of
- +14 more
Dec 14, 2020
Rheumatoid Arthritis Trial in Worldwide (Filgotinib, Placebo to match filgotinib, csDMARDs)
Psoriatic Arthritis Trial in Gent, Brussels (Global/single cell gene expression profiles obtained from Synovial biopsies)
Recruiting
- Psoriatic Arthritis
- Global/single cell gene expression profiles obtained from Synovial biopsies
-
Gent, East Flanders, Belgium
- +1 more
Mar 16, 2021
Arthritis, Psoriatic Trial in Worldwide (Placebo matching BMS-945429, BMS-945429)
Completed
- Arthritis, Psoriatic
- Placebo matching BMS-945429
- BMS-945429
-
San Diego, California
- +48 more
Oct 7, 2021
Tofacitinib in Treatment-Resistant Rheumatoid Arthritis
Completed
- Rheumatoid Arthritis
- Treatment Adherence and Compliance
- (no location specified)
Dec 12, 2020
Active Polyarticular Juvenile Idiopathic Arthritis Trial in Worldwide (Abatacept)
Active, not recruiting
- Active Polyarticular Juvenile Idiopathic Arthritis
- Abatacept
-
Birmingham, Alabama
- +54 more
Nov 17, 2021
Rheumatoid Arthritis Trial (Baricitinib 4 MG, Placebo)
Not yet recruiting
- Rheumatoid Arthritis
- Baricitinib 4 MG
- Placebo
- (no location specified)
Jul 27, 2023
Rheumatoid Arthritis Trial ("apigenin" and "glycyrrhizin", "glycyrrhizin" and "boswellic acid", "")
Not yet recruiting
- Rheumatoid Arthritis
- "apigenin" and "glycyrrhizin"
- +2 more
- (no location specified)
Mar 27, 2023
Rheumatoid Arthritis Trial in United States (procedure, drug, device)
Recruiting
- Rheumatoid Arthritis
- Implant Procedure
- +3 more
-
Birmingham, Alabama
- +33 more
Jan 3, 2023
Incident IMID in Patients Treated With Biologics and
Not yet recruiting
- Inflammatory Disease
-
Paris, FranceHôpital Saint-Antoine
Jan 23, 2023
Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis Trial in São Paulo (Recombinant Herpes Zoster Vaccine (RZV),
Recruiting
- Rheumatoid Arthritis
- +9 more
- Recombinant Herpes Zoster Vaccine (RZV)
- +5 more
-
São Paulo, Sao Paulo, BrazilRheumatology Division of Hospital das Clínicas da Faculdade de M
May 24, 2023
Inhibitors of Jak Kinases in Patients With Rheumatoid Arthritis.
Recruiting
- Arthritis, Rheumatoid
-
Sevilla, SpainHospital Universitario Virgen macarena
Nov 15, 2021